Short Interest in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Decreases By 64.1%

Bioceres Crop Solutions Corp. (NASDAQ:BIOXGet Free Report) was the recipient of a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 327,738 shares, a decline of 64.1% from the August 15th total of 913,482 shares. Based on an average trading volume of 718,829 shares, the short-interest ratio is currently 0.5 days. Currently, 0.5% of the company’s shares are sold short.

Institutional Investors Weigh In On Bioceres Crop Solutions

Institutional investors and hedge funds have recently made changes to their positions in the stock. GAM Holding AG acquired a new stake in shares of Bioceres Crop Solutions during the 4th quarter worth about $655,000. Ardsley Advisory Partners LP lifted its position in Bioceres Crop Solutions by 691.7% during the fourth quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock worth $622,000 after acquiring an additional 415,000 shares during the last quarter. Marshall Wace LLP boosted its holdings in shares of Bioceres Crop Solutions by 180.0% during the fourth quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock worth $780,000 after acquiring an additional 382,744 shares during the period. Susquehanna International Group LLP acquired a new position in shares of Bioceres Crop Solutions in the third quarter valued at approximately $315,000. Finally, State of Wisconsin Investment Board acquired a new position in shares of Bioceres Crop Solutions in the fourth quarter valued at approximately $247,000. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Down 0.8%

Shares of NASDAQ BIOX traded down $0.00 during mid-day trading on Friday, hitting $0.42. The company had a trading volume of 63,480 shares, compared to its average volume of 470,305. Bioceres Crop Solutions has a one year low of $0.30 and a one year high of $2.19. The company has a market capitalization of $26.50 million, a PE ratio of -0.11 and a beta of 0.44. The company has a current ratio of 0.88, a quick ratio of 0.70 and a debt-to-equity ratio of 0.57. The firm has a 50-day simple moving average of $0.38 and a two-hundred day simple moving average of $0.44.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a report on Monday, July 13th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Bioceres Crop Solutions currently has a consensus rating of “Reduce” and an average target price of $2.00.

Check Out Our Latest Stock Analysis on BIOX

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.

Featured Articles

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.